Business DRAP CEO rules out impact of 17% GST on prices of medicines LAHORE: The Chief Executive Officer of the Drug Regulatory Authority of Pakistan (DRAP), Asim Rauf on Thursday ruled out of increase in prices of medicines after the imposition Muhammad Jahangir4 years agoKeep Reading